An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness

References

• Milbrandt E, Kersten A, Rahim M, Dremsizov T, Clermont G, Cooper L, Angus D. 2008. Growth of intensive care unit resource use and its estimated cost in medicare. Crit Care Med. 36(9):2504–25. doi:10.1097/CCM.0b013e318183ef84.
   Google Scholar
• Brun-Buisson C. 2000. The epidemiology of the systemic inflammatory response. Intensive Care Med [Internet]. 26(S1):S064–74. doi:10.1007/s001340051121.
   Google Scholar
• Adib-Conquy M, Cavaillon JM. 2009. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 101(1):36–47. doi:10.1160/TH08-07-0421.
   Google Scholar
• Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, et al. 2011.Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA - J Am Med Assoc. 306(23):2594–2605. doi:10.1001/jama.2011.1829.
   Google Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 29(7):1303–1310. doi:10.1097/00003246-200107000-00002.
   Google Scholar
• Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, et al. 2020. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA [Internet]. 323(15):1478. doi:10.1001/jama.2020.2717.
   Google Scholar
• Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. 2017. Surviving sepsis campaign. Crit Care Med. 45:486–552.
   Google Scholar
• Silvestri L, De La Cal M, Van Saene H. Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth. Intensive Care Med. 2012;38.
   Google Scholar
• Fridkin S, Baggs J, Fagan R, Magill S, Pollack LA, Malpiedi P, Slayton R, Khader K, Rubin MA, Jones M, et al. 2014. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep [Internet]. 63:194–200. Available from. http://www.ncbi.nlm.nih.gov/pubmed/24598596%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4584728
   Google Scholar
• Ravi A, Halstead FD, Bamford A, Casey A, Thomson NM, van Schaik W, Snelson C, Goulden R, Foster-Nyarko E, Gm S, et al. 2019. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients. Microb Genomics [Internet]. 5(9).
   Google Scholar
• McKenney PT, Pamer EG. 2015. From hype to hope: the gut microbiota in enteric infectious disease. Cell [Internet] ; 163(6):1326–1332. doi:10.1016/j.cell.2015.11.032.
   Google Scholar
• Jacobson A, Lam L, Rajendram M, Tamburini F, Honeycutt J, Pham T, Van Treuren W, Pruss K, Stabler SR, Lugo K, et al. 2018. A gut commensal-produced metabolite mediates colonization resistance to salmonella infection. Cell Host Microbe [Internet] ; 24(2):296–307.e7. doi:10.1016/j.chom.2018.07.002.
   Google Scholar
• Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, et al. 2011.Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 469(7331):543–547. doi:10.1038/nature09646.
   Google Scholar
• Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee I-K, Yun B-S, Matsuzaki K, Furukawa M, Min H-K, Bajaj JS, et al. 2019. Bile acid 7α-Dehydroxylating gut bacteria secrete antibiotics that inhibit clostridium difficile: role of secondary bile acids. Cell Chem Biol Internet]. 26(1):27–34.e4. doi:10.1016/j.chembiol.2018.10.003.
   Google Scholar
• Alavi S, Mitchell JD, Cho JY, Liu R, Macbeth JC, Hsiao A. 2020. Interpersonal gut microbiome variation drives susceptibility and resistance to cholera infection. Cell [Internet]. 181(7):1533–1546.e13. doi:10.1016/j.cell.2020.05.036.
   Google Scholar
• Hand TW. 2016. The role of the microbiota in shaping infectious immunity. Trends Immunol Internet. 37(10):647–658. doi:10.1016/j.it.2016.08.007.
   Google Scholar
• Armour CR, Nayfach S, Pollard KS, Sharpton TJ. 2019. A metagenomic meta-analysis reveals functional signatures of health and disease in the human gut microbiome. mSystems. 4(4):1–15. doi:10.1128/mSystems.00332-18.
   Google Scholar
• McDonald D, Ackermann G, Khailova L, Baird C, Heyland D, Kozar R, Lemieux M, Derenski K, King J, Vis-Kampen C, et al. 2016. Extreme dysbiosis of the microbiome in critical illness. mSphere [Internet]. 1(4).
   Google Scholar
• Hernández-Santos N, Klein BS. 2017. Through the scope darkly: the Gut mycobiome comes into focus. Cell Host Microbe. 22(6):728–729. doi:10.1016/j.chom.2017.11.013.
   Google Scholar
• Zhang E, Tanaka T, Tajima M, Tsuboi R, Nishikawa A, Sugita T. 2011. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol Immunol. 55(9):625–632. doi:10.1111/j.1348-0421.2011.00364.x.
   Google Scholar
• Huseyin CE, O’Toole PW, Cotter PD, Scanlan PD. 2017. Forgotten fungi-the gut mycobiome in human health and disease. FEMS Microbiol Rev.
   Google Scholar
• Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM. 2010. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 6(1):e1000713. doi:10.1371/journal.ppat.1000713.
   Google Scholar
• Nguyen LDN, Viscogliosi E, Delhaes L. 2015. The lung mycobiome: an emerging field of the human respiratory microbiome. Front Microbiol. 6. doi:10.3389/fmicb.2015.00089.
   Google Scholar
• Witherden EA, Moyes DL. Mycrobiome and gut inflammation: implications in gut disease. In: Immunity and inflammation in health and disease. Elsevier; 2018. p. 271–280.
   Google Scholar
• van Woerden HC, Gregory C, Brown R, Marchesi JR, Hoogendoorn B, Matthews IP. 2013. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect Dis. 13(1). doi:10.1186/1471-2334-13-69.
   Google Scholar
• Hoffmann C, Dollive S, Grunberg S, Chen J, Li H, Wu GD, Lewis JD, Bushman FD. 2013. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One.
   Google Scholar
• Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, et al. 2017. Fungal microbiota dysbiosis in IBD. Gut. 66(6):1039–1048. doi:10.1136/gutjnl-2015-310746.
   Google Scholar
• Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, Panzer AR, Lamere B, Rackaityte E, Lukacs NW, et al. 2016. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 22(10):1187–1191. doi:10.1038/nm.4176.
   Google Scholar
• Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T. 2015. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS Pathog. 11(1):e1004523. doi:10.1371/journal.ppat.1004523.
   Google Scholar
• Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y, et al. 2017. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 127(7):2829–2841. doi:10.1172/JCI90562.
   Google Scholar
• Dollive S, Chen YY, Grunberg S, Bittinger K, Hoffmann C, Vandivier L, Cuff C, Lewis JD, Wu GD, Bushman FD. 2013. Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One. 8(8):e71806. doi:10.1371/journal.pone.0071806.
   Google Scholar
• Noverr MC, Noggle RM, Toews GB, Huffnagle GB. 2004. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun. 72(9):4996–5003. doi:10.1128/IAI.72.9.4996-5003.2004.
   Google Scholar
• Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, Koh AY. 2015. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med.
   Google Scholar
• Krause R, Halwachs B, Thallinger GG, Klymiuk I, Gorkiewicz G, Hoenigl M, Prattes J, Valentin T, Heidrich K, Buzina W, et al. 2016.Characterisation of Candida within the mycrobiome/microbiome of the lower respiratory tract of ICU patients. PLoS One. 11(5):1–29. doi:10.1371/journal.pone.0155033.
   Google Scholar
• Krause R, Moissl-Eichinger C, Halwachs B, Gorkiewicz G, Berg G, Valentin T, Prattes J, Högenauer C, Zollner-Schwetz I. 2017. Mycrobiome in the lower respiratory tract – a clinical perspective. Front Microbiol. 07. doi:10.3389/fmicb.2016.02169.
   Google Scholar
• Arastehfar A, Carvalho A, Nguyen MH, Hedayati MT, Netea MG, Perlin DS, Hoenigl M. 2020. COVID-19-Associated Candidiasis (CAC): an underestimated complication in the absence of immunological predispositions? J Fungi. 6(4):211. doi:10.3390/jof6040211.
   Google Scholar
• Lagunes L, Rello J. 2016. Invasive candidiasis: from mycobiome to infection, therapy, and prevention. Eur J Clin Microbiol Infect Dis. 35(8):1221–1226. doi:10.1007/s10096-016-2658-0.
   Google Scholar
• Watkins RR, Mukherjee PK, Chandra J, Retuerto MA, Guidry C, Haller N, Paranjape C, Ghannoum MA. 2017. Admission to the intensive care unit is associated with changes in the oral mycobiome. J Intensive Care Med. 32(4):278–282. doi:10.1177/0885066615627757.
   Google Scholar
• Heisel T, Nyaribo L, Sadowsky MJ, Gale CA. 2019. Breastmilk and NICU surfaces are potential sources of fungi for infant mycrobiomes. Fungal Genet Biol. 128:29–35. doi:10.1016/j.fgb.2019.03.008.
   Google Scholar
• Seelbinder B, Chen J, Brunke S, Vazquez-Uribe R, Santhaman R, Meyer AC, De Oliveira Lino FS, Chan KF, Loos D, Imamovic L, et al. 2020. Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria. Microbiome. 8(1). doi:10.1186/s40168-020-00899-6.
   Google Scholar
• Calandra T, Cohen J. 2005. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 33(7):1538–1548. doi:10.1097/01.CCM.0000168253.91200.83.
   Google Scholar
• Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, Tett A, Huttenhower C, Segata N. 2015. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods [Internet]. 12(10):902–903. doi:10.1038/nmeth.3589.
   Google Scholar
• Shenhav L, Thompson M, Joseph TA, Briscoe L, Furman O, Bogumil D, Mizrahi I, Pe’er I, Halperin E. 2019. FEAST: fast expectation-maximization for microbial source tracking. Nat Methods. 16(7):627–632. [Internet]. doi:10.1038/s41592-019-0431-x.
   Google Scholar
• Abeles SR, Jones MB, Santiago-Rodriguez TM, Ly M, Klitgord N, Yooseph S, Nelson KE, Pride DT. 2016. Microbial diversity in individuals and their household contacts following typical antibiotic courses. Microbiome [Internet]. 4(1):39. doi:10.1186/s40168-016-0187-9.
   Google Scholar
• Burdet C, Nguyen TT, Duval X, Ferreira S, Andremont A, Guedj J, Mentré F, Cherng B, Su Gin DC, Rama ND, et al. 2019. Impact of antibiotic gut exposure on the temporal changes in microbiome diversity. Antimicrob Agents Chemother [Internet]. 63. https://aac.asm.org/content/63/10/e00820-19.
   Google Scholar
• Nielsen HB, Almeida M, Juncker AS, Rasmussen S, Li J, Sunagawa S, Plichta DR, Gautier L, Pedersen AG, Le Chatelier E, et al. 2014. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol. 32(8):822–828. doi:10.1038/nbt.2939.
   Google Scholar
• Foster ZSL, Sharpton TJ, Grünwald NJ. 2017. Metacoder: an R package for visualization and manipulation of community taxonomic diversity data. PLOS Comput Biol [Internet]. 13(2):e1005404. doi:10.1371/journal.pcbi.1005404.
   Google Scholar
• Fiore E, Van Tyne D, Gilmore MS. 2019. Pathogenicity of Enterococci. Microbiol Spectr [Internet]. 7(4).
   Google Scholar
• Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, Lipson KS, Knight R, Caporaso JG, Segata N, et al. 2018. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods [Internet]. 15(11):962–968. doi:10.1038/s41592-018-0176-y.
   Google Scholar
• Pasolli E, Schiffer L, Manghi P, Renson A, Obenchain V, Truong DT, Beghini F, Malik F, Ramos M, Dowd JB, et al. 2017. Accessible, curated metagenomic data through experimentHub. Nat Methods [Internet]. 14(11):1023–1024. doi:10.1038/nmeth.4468.
   Google Scholar
• Hannigan GD, Duhaime MB, Ruffin MT, Koumpouras CC, Schloss PD. 2018. Diagnostic potential and interactive dynamics of the colorectal cancer virome. MBio. 9(6). doi:10.1128/mBio.02248-18.
   Google Scholar
• Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, et al. 2015. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 6(1):6528. doi:10.1038/ncomms7528.
   Google Scholar
• Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, Beghini F, Manara S, Karcher N, Pozzi C, et al. 2019. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 25:667–678.
   Google Scholar
• Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, Goedert JJ, Shi J, Bork P, Sinha R. 2016. Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS One. 11(5):e0155362. doi:10.1371/journal.pone.0155362.
   Google Scholar
• Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, Tang L, Zhao H, Stenvang J, Li Y, et al. 2017. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 66(1):70–78. doi:10.1136/gutjnl-2015-309800.
   Google Scholar
• Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, et al. 2014. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 10(11):766. doi:10.15252/msb.20145645.
   Google Scholar
• Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. 2018. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 359(6371):97–103. doi:10.1126/science.aan4236.
   Google Scholar
• Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, Luke JJ, Gajewski TF. 2018. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 359(6371):104–108. doi:10.1126/science.aao3290.
   Google Scholar
• Wen C, Zheng Z, Shao T, Liu L, Xie Z, Le Chatelier E, He Z, Zhong W, Fan Y, Zhang L, et al. 2017. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol. 18(1):142. doi:10.1186/s13059-017-1271-6.
   Google Scholar
• Jie Z, Xia H, Zhong S-L, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, et al. 2017.The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 8(1):845. doi:10.1038/s41467-017-00900-1.
   Google Scholar
• Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, Du L, Cao Q, Tang J, Zhou C, et al. 2018.A metagenomic study of the gut microbiome in Behcet’s disease. Microbiome. 6(1):135. doi:10.1186/s40168-018-0520-6.
   Google Scholar
• Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. 2017.Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 5(1):1–19. doi:10.1186/s40168-016-0222-x.
   Google Scholar
• Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al. 2014. Alterations of the human gut microbiome in liver cirrhosis. Nature [Internet]. 513(7516):59–64. 10.1038/nature13568.
   Google Scholar
• Li SS, Zhu A, Benes V, Costea PI, Hercog R, Hildebrand F, Huerta-Cepas J, Nieuwdorp M, Salojärvi J, Voigt AY, et al. 2016.Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science. 352(6285):586–589. doi:10.1126/science.aad8852.
   Google Scholar
• Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, et al. 2017.Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 25(5):1054–1062.e5. doi:10.1016/j.cmet.2017.04.001.
   Google Scholar
• Louis S, Tappu R-M, Damms-Machado A, Huson DH, Bischoff SC. 2016. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLoS One. 11(2):e0149564. doi:10.1371/journal.pone.0149564.
   Google Scholar
• Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M, Kennedy S, et al. 2013.Richness of human gut microbiome correlates with metabolic markers. Nature. 500(7464):541–546. doi:10.1038/nature12506.
   Google Scholar
• Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen A-M, Peet A, Tillmann V, Pöhö P, Mattila I, et al. 2015.The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 17(2):260–273. doi:10.1016/j.chom.2015.01.001.
   Google Scholar
• Heintz-Buschart A, May P, Laczny CC, Lebrun LA, Bellora C, Krishna A, Wampach L, Schneider JG, Hogan A, De Beaufort C, et al. 2016. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat Microbiol. 2:16180. doi:10.1038/nmicrobiol.2016.180.
   Google Scholar
• Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F. 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 498(7452):99–103. doi:10.1038/nature12198.
   Google Scholar
• Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. 2012.A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 490(7418):55–60. doi:10.1038/nature11450.
   Google Scholar
• Kieser S, Sarker SA, Sakwinska O, Foata F, Sultana S, Khan Z, Islam S, Porta N, Combremont S, Betrisey B, et al. 2018. Bangladeshi children with acute diarrhoea show faecal microbiomes with increased Streptococcus abundance, irrespective of diarrhoea aetiology. Environ Microbiol [Internet]. 20(6):2256–2269. doi:10.1111/1462-2920.14274.
   Google Scholar
• Vincent C, Miller MA, Edens TJ, Mehrotra S, Dewar K, Manges AR. 2016. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection. Microbiome [Internet]. 4(1):12. doi:10.1186/s40168-016-0156-3.
   Google Scholar
• David LA, Weil A, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ. 2015. Gut microbial succession follows acute secretory diarrhea in humans. MBio [Internet]. 6(3):e00381–15. doi:10.1128/mBio.00381-15.
   Google Scholar
• Dixon P. 2003. VEGAN, a package of R functions for community ecology. J Veg Sci [Internet]. 14(6):927–930. doi:10.1111/j.1654-1103.2003.tb02228.x.
   Google Scholar
• Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. 2019. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. MBio [Internet]. 10(1):e02566–18. doi:10.1128/mBio.02566-18.
   Google Scholar
• Heinken A, Ravcheev DA, Baldini F, Heirendt L, Fleming RMT, Thiele I. 2019. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease. Microbiome. 7(1):1–18. doi:10.1186/s40168-019-0689-3.
   Google Scholar
• Mukherjee A, Lordan C, Ross RP, Cotter PD. 2020. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes [Internet]. 12(1):1802866. doi:10.1080/19490976.2020.1802866.
   Google Scholar
• Podschun R, Ullmann U. 1998. Klebsiella spp. as Nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev Internet]. 11(4):589–603. doi:10.1128/CMR.11.4.589.
   Google Scholar
• Devlin AS, Fischbach MA. 2015. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol [Internet]. 11(9):685–690: doi:10.1038/nchembio.1864.
   Google Scholar
• Liu H, Tian R, Wang H, Feng S, Li H, Xiao Y, Luan X, Zhang Z, Shi N, Niu H, et al. 2020. Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation. J Transl Med [Internet]. 18(1):382. doi:10.1186/s12967-020-02539-x.
   Google Scholar
• Morrison DJ, Preston T. 2016. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes [Internet]. 7(3):189–200. doi:10.1080/19490976.2015.1134082.
   Google Scholar
• Mirković B, Murray MA, Lavelle GM, Molloy K, Azim AA, Gunaratnam C, Healy F, Slattery D, McNally P, Hatch J, et al. 2015. The role of short-chain fatty acids, produced by anaerobic bacteria, in the cystic fibrosis airway. Am J Respir Crit Care Med [Internet]. 192(11):1314–1324. doi:10.1164/rccm.201505-0943OC.
   Google Scholar
• Horiuchi H, Kamikado K, Aoki R, Suganuma N, Nishijima T, Nakatani A, Kimura I. 2020. Bifidobacterium animalis subsp. lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43. Sci Rep [Internet]. 10(1):4158. doi:10.1038/s41598-020-60984-6.
   Google Scholar
• Magnúsdóttir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, Greenhalgh K, Jäger C, Baginska J, Wilmes P, et al. 2017. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat Biotechnol [Internet]. 35(1):81–89. doi:10.1038/nbt.3703.
   Google Scholar
• Pons MJ, Ruiz J. 2019. Current trends in epidemiology and antimicrobial resistance in intensive care units. J Emerg Crit Care Med [Internet]. 3:5. doi:10.21037/jeccm.2019.01.05.
   Google Scholar
• Han B, Sivaramakrishnan P, Lin -C-CJ, Neve IAA, He J, Tay LWR, Sowa JN, Sizovs A, Du G, Wang J, et al. 2017. Microbial genetic composition tunes host longevity. Cell [Internet]. 169:1249–1262.e13. http://www.ncbi.nlm.nih.gov/pubmed/28622510
   Google Scholar
• Mahadevan R, Schilling CH. 2003. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng [Internet]. 5(4):264–276. doi:10.1016/j.ymben.2003.09.002.
   Google Scholar
• Emiola A, Oh J. 2018. High throughput in situ metagenomic measurement of bacterial replication at ultra-low sequencing coverage. Nat Commun [Internet]. 9(1):4956. doi:10.1038/s41467-018-07240-8.
   Google Scholar
• Libina N, Berman JR, Kenyon C. 2003. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell. 115(4):489–502. doi:10.1016/S0092-8674(03)00889-4.
   Google Scholar
• Murphy CT. 2006. The search for DAF-16/FOXO transcriptional targets: approaches and discoveries. Exp Gerontol. 41(10):910–921. doi:10.1016/j.exger.2006.06.040.
   Google Scholar
• Kenyon CJ. 2010. The genetics of ageing. Nature.
   Google Scholar
• Jungersen M, Wind A, Johansen E, Christensen JE, Stuer-Lauridsen B, Eskesen D. 2014. The science behind the probiotic strain bifidobacterium animalis subsp. lactis BB-12(®). Microorganisms [Internet]. 2:92–110. (2): doi:10.3390/microorganisms2020092.
   Google Scholar
• Paumgartner G. 2002. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology [Internet]. 36:525–531. (3):doi:10.1053/jhep.2002.36088.
   Google Scholar
• Keely SJ, Steer CJ, Lajczak-McGinley NK. 2019. Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases? Am J Physiol Liver Physiol [Internet]. 317:G872–81.
   Google Scholar
• Theriot CM, Bowman AA, Young VB. 2016. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for clostridium difficile spore germination and outgrowth in the large intestine. mSphere. 1(1). doi:10.1128/mSphere.00045-15.
   Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. 2016. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods [Internet]. 13(7):581–583. doi:10.1038/nmeth.3869.
   Google Scholar
• Arango-Argoty G, Garner E, Pruden A, Heath LS, Vikesland P, Zhang L. 2018. DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data. Microbiome. 6(1):1–15. doi:10.1186/s40168-018-0401-z.
   Google Scholar
• Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, et al. 2018. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature [Internet]. 555(7698):623–628. doi:10.1038/nature25979.
   Google Scholar
• Sörgel F. 2004. The return of Ehrlich’s ‘Therapia magna sterilisans’ and other Ehrlich concepts? Chemotherapy. 50(1):6–10. doi:10.1159/000077277.
   Google Scholar
• Khaliq W, Großmann P, Neugebauer S, Kleyman A, Domizi R, Calcinaro S, Brealey D, Gräler M, Kiehntopf M, Schäuble S, et al. 2020. Lipid metabolic signatures deviate in sepsis survivors compared to non-survivors. Comput Struct Biotechnol J. 18:3678–3691. doi:10.1016/j.csbj.2020.11.009.
   Google Scholar
• Kim SM, DeFazio JR, Hyoju SK, Sangani K, Keskey R, Krezalek MA, Khodarev NN, Sangwan N, Christley S, Harris KG, et al. 2020. Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity. Nat Commun [ [Internet]. 11:1–11. doi:10.1038/s41467-020-15545-w.
   Google Scholar
• Singer JR, Blosser EG, Zindl CL, Silberger DJ, Conlan S, Laufer VA, DiToro D, Deming C, Kumar R, Morrow CD, et al. 2019. Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis. Nat Med [Internet]. 25(11):1772–1782. doi:10.1038/s41591-019-0640-y.
   Google Scholar
• Nguyen TLA, Vieira-Silva S, Liston A, Raes J. 2015. How informative is the mouse for human gut microbiota research? Dis Model Mech [Internet]. 8:1–16. doi:10.1242/dmm.017400.
   Google Scholar
• Esper AM, Martin GS. 2011. The impact of comorbid conditions on critical illness. Crit Care Med [Internet]. 39(12):2728–2735. doi:10.1097/CCM.0b013e318236f27e.
   Google Scholar
• Huber-Lang M, Lambris JD, Ward PA. 2018. Innate immune responses to trauma. Nat Immunol [Internet]. 19(4):327–341. doi:10.1038/s41590-018-0064-8.
   Google Scholar
• Ladopoulos T. 2018. Gastrointestinal dysmotility in critically ill patients. Ann Gastroenterol [ [Internet]. Available from]. http://www.annalsgastro.gr/files/journals/1/earlyview/2018/ev-03-2018-10-AG3394-0250.pdf
   Google Scholar
• Alonso-Echanove J, Gaynes RP. Scope and magnitude of nosocomial ICU infections. [Internet]. 2001.
   Google Scholar
• Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J. 2017. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis [Internet]. 65(4):644–652. :doi:10.1093/cid/cix411.
   Google Scholar
• Johnsen LG, Skou PB, Khakimov B, Bro R. 2017. Gas chromatography – mass spectrometry data processing made easy. J Chromatogr A [Internet]. 1503:57–64. Available from. https://linkinghub.elsevier.com/retrieve/pii/S0021967317306489.
   Google Scholar
• Li J, Sung CYJ, Lee N, Ni Y, Pihlajamäki J, Panagiotou G, El-Nezami H. 2016. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci [Internet]. 113(9):E1306–15. doi:10.1073/pnas.1518189113.
   Google Scholar
• Li H. 2013. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Oxford Univ Press.
   Google Scholar
• Wang Q, Garrity GM, Tiedje JM, Cole JR. 2007. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol [Internet] ; 73(16):5261–5267. doi:10.1128/AEM.00062-07.
   Google Scholar
• Paulson JN, Stine OC, Bravo HC, Pop M. 2013. Differential abundance analysis for microbial marker-gene surveys. Nat Methods [Internet]. 10(12):1200–1202. doi:10.1038/nmeth.2658.
   Google Scholar
• Vavrek MJ. 2011. fossil: palaeoecological and palaeogeographical analysis tools. Palaeontol Electron. 14.
   Google Scholar
• Friedman J, Alm EJ. 2012. Inferring correlation networks from genomic survey data. PLoS Comput Biol. 8(9):1–11. doi:10.1371/journal.pcbi.1002687.
   Google Scholar
• Brunk E, Sahoo S, Zielinski DC, Altunkaya A, Dräger A, Mih N, Gatto F, Nilsson A, Preciat Gonzalez GA, Aurich MK, et al. 2018. Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat Biotechnol [Internet]. 36(3):272–281. doi:10.1038/nbt.4072.
   Google Scholar
• Machado D, Andrejev S, Tramontano M, Patil KR. 2018. Fast automated reconstruction of genome-scale metabolic models for microbial species and communities. Nucleic Acids Res [Internet]. 46(15):7542–7553. doi:10.1093/nar/gky537.
   Google Scholar
• Ho J, Tumkaya T, Aryal S, Choi H, Claridge-Chang A. 2019. Moving beyond P values: data analysis with estimation graphics. Nat Methods [Internet]. 16(7):565–566. doi:10.1038/s41592-019-0470-3.
   Google Scholar
• Kuhn M. 2008. Caret package. J Stat Softw. 28.
   Google Scholar
• Grau J, Grosse I, Keilwagen J. 2015. PRROC: computing and visualizing Precision-recall and receiver operating characteristic curves in R. Bioinformatics. 31(15):2595–2597. doi:10.1093/bioinformatics/btv153.
   Google Scholar
• Xiong H, Pears C, Woollard A. 2017. An enhanced C. elegans based platform for toxicity assessment. Sci Rep [Internet]. 7(1):9839. doi:10.1038/s41598-017-10454-3.
   Google Scholar
• Chawla DG, Shah RV, Barth ZK, Lee JD, Badecker KE, Naik A, Brewster MM, Salmon TP, Peel N. 2016. Caenorhabditis elegans glutamylating enzymes function redundantly in male mating. Biol Open [Internet]. 5:1290–1298. (9): doi:10.1242/bio.017442.
   Google Scholar